Inozyme Pharma Inc (INZY) — Long-term Investment Intensity
Inozyme Pharma Inc (INZY) has a Long-term Investment Intensity of 1.6% as of March 2021. Long-term investments of $2.55 Million represent 1.6% of total assets of $158.91 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore Inozyme Pharma Inc (INZY) cash conversion ratio to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Inozyme Pharma Inc Long-term Investment Intensity (2020–2020)
This chart shows how Inozyme Pharma Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2020 to 2020. As of March 2021, the intensity stands at 1.6%, reflecting long-term investments of $2.55 Million against total assets of $158.91 Million USD. Explore INZY cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Inozyme Pharma Inc (2020–2020)
The table below presents the year-by-year Long-term Investment Intensity for Inozyme Pharma Inc from 2020 to 2020, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Inozyme Pharma Inc worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 7.2% | $12.20 Million | $169.36 Million | — |